Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1999 Apr;36(4):316–322.

ERG phenotype of a dystrophin mutation in heterozygous female carriers of Duchenne muscular dystrophy

K Fitzgerald 1, G Cibis 1, A H Gettel 1, R Rinaldi 1, D Harris 1, R White 1
PMCID: PMC1734342  PMID: 10227401

Abstract

PURPOSE—Mutations in the dystrophin gene result in Duchenne muscular dystrophy (DMD). DMD is associated with an abnormal electroretinogram (ERG) if the mutation disrupts the translation of retinal dystrophin (Dp260). Our aim was to determine if incomplete ERG abnormalities would be associated with heterozygous carriers of dystrophin gene mutations.
METHODS—Ganzfeld ERGs were obtained under scotopic and photopic testing conditions from a family which includes the heterozygous maternal grandmother, the heterozygous mother, and her children, two affected boys and dizygotic twin sibs, an unaffected male and heterozygous female. Southern blot analyses were done to characterise the dystrophin mutation.
RESULTS—The dystrophin gene was found to contain a deletion encompassing exon 50. The ERGs in the two affected boys were abnormal, consistent with the DMD ERG phenotype. Serial ERGs of the heterozygous females were abnormal; however, they were less severely affected than the DMD boys. The ERG of the female sib showed a greater abnormality than her mother and maternal grandmother. The unaffected twin had a normal ERG.
CONCLUSIONS—The ERG shows abnormalities associated with carrier status in this family with a single exon deletion. A large study of confirmed obligate carriers is planned to clarify further the value of the ERG in detecting female heterozygous carriers of dystrophin gene mutations.


Keywords: muscular dystrophy; electroretinography; retina; dystrophin

Full Text

The Full Text of this article is available as a PDF (125.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahn A. H., Kunkel L. M. The structural and functional diversity of dystrophin. Nat Genet. 1993 Apr;3(4):283–291. doi: 10.1038/ng0493-283. [DOI] [PubMed] [Google Scholar]
  2. Byers T. J., Lidov H. G., Kunkel L. M. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet. 1993 May;4(1):77–81. doi: 10.1038/ng0593-77. [DOI] [PubMed] [Google Scholar]
  3. Cibis G. W., Fitzgerald K. M., Harris D. J., Rothberg P. G., Rupani M. The effects of dystrophin gene mutations on the ERG in mice and humans. Invest Ophthalmol Vis Sci. 1993 Dec;34(13):3646–3652. [PubMed] [Google Scholar]
  4. Cox G. A., Phelps S. F., Chapman V. M., Chamberlain J. S. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nat Genet. 1993 May;4(1):87–93. doi: 10.1038/ng0593-87. [DOI] [PubMed] [Google Scholar]
  5. D'Souza V. N., Nguyen T. M., Morris G. E., Karges W., Pillers D. A., Ray P. N. A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet. 1995 May;4(5):837–842. doi: 10.1093/hmg/4.5.837. [DOI] [PubMed] [Google Scholar]
  6. Darras B. T., Blattner P., Harper J. F., Spiro A. J., Alter S., Francke U. Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations. Am J Hum Genet. 1988 Nov;43(5):620–629. [PMC free article] [PubMed] [Google Scholar]
  7. Darras B. T., Francke U. Normal human genomic restriction-fragment patterns and polymorphisms revealed by hybridization with the entire dystrophin cDNA. Am J Hum Genet. 1988 Nov;43(5):612–619. [PMC free article] [PubMed] [Google Scholar]
  8. De Becker I., Riddell D. C., Dooley J. M., Tremblay F. Correlation between electroretinogram findings and molecular analysis in the Duchenne muscular dystrophy phenotype. Br J Ophthalmol. 1994 Sep;78(9):719–722. doi: 10.1136/bjo.78.9.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fitzgerald K. M., Cibis G. W., Giambrone S. A., Harris D. J. Retinal signal transmission in Duchenne muscular dystrophy: evidence for dysfunction in the photoreceptor/depolarizing bipolar cell pathway. J Clin Invest. 1994 Jun;93(6):2425–2430. doi: 10.1172/JCI117250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Górecki D. C., Barnard E. A. Specific expression of G-dystrophin (Dp71) in the brain. Neuroreport. 1995 Apr 19;6(6):893–896. doi: 10.1097/00001756-199504190-00017. [DOI] [PubMed] [Google Scholar]
  11. Hoffman E. P., Brown R. H., Jr, Kunkel L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987 Dec 24;51(6):919–928. doi: 10.1016/0092-8674(87)90579-4. [DOI] [PubMed] [Google Scholar]
  12. Jensen H., Warburg M., Sjö O., Schwartz M. Duchenne muscular dystrophy: negative electroretinograms and normal dark adaptation. Reappraisal of assignment of X linked incomplete congenital stationary night blindness. J Med Genet. 1995 May;32(5):348–351. doi: 10.1136/jmg.32.5.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kameya S., Araki E., Katsuki M., Mizota A., Adachi E., Nakahara K., Nonaka I., Sakuragi S., Takeda S., Nabeshima Y. Dp260 disrupted mice revealed prolonged implicit time of the b-wave in ERG and loss of accumulation of beta-dystroglycan in the outer plexiform layer of the retina. Hum Mol Genet. 1997 Dec;6(13):2195–2203. doi: 10.1093/hmg/6.13.2195. [DOI] [PubMed] [Google Scholar]
  14. Koenig M., Beggs A. H., Moyer M., Scherpf S., Heindrich K., Bettecken T., Meng G., Müller C. R., Lindlöf M., Kaariainen H. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 1989 Oct;45(4):498–506. [PMC free article] [PubMed] [Google Scholar]
  15. Koenig M., Monaco A. P., Kunkel L. M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988 Apr 22;53(2):219–228. doi: 10.1016/0092-8674(88)90383-2. [DOI] [PubMed] [Google Scholar]
  16. Lederfein D., Levy Z., Augier N., Mornet D., Morris G., Fuchs O., Yaffe D., Nudel U. A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5346–5350. doi: 10.1073/pnas.89.12.5346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lidov H. G., Byers T. J., Watkins S. C., Kunkel L. M. Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature. 1990 Dec 20;348(6303):725–728. doi: 10.1038/348725a0. [DOI] [PubMed] [Google Scholar]
  18. Lidov H. G., Selig S., Kunkel L. M. Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet. 1995 Mar;4(3):329–335. doi: 10.1093/hmg/4.3.329. [DOI] [PubMed] [Google Scholar]
  19. Montanaro F., Carbonetto S., Campbell K. P., Lindenbaum M. Dystroglycan expression in the wild type and mdx mouse neural retina: synaptic colocalization with dystrophin, dystrophin-related protein but not laminin. J Neurosci Res. 1995 Nov 1;42(4):528–538. doi: 10.1002/jnr.490420411. [DOI] [PubMed] [Google Scholar]
  20. Pillers D. A., Bulman D. E., Weleber R. G., Sigesmund D. A., Musarella M. A., Powell B. R., Murphey W. H., Westall C., Panton C., Becker L. E. Dystrophin expression in the human retina is required for normal function as defined by electroretinography. Nat Genet. 1993 May;4(1):82–86. doi: 10.1038/ng0593-82. [DOI] [PubMed] [Google Scholar]
  21. Pillers D. A., Seltzer W. K., Powell B. R., Ray P. N., Tremblay F., La Roche G. R., Lewis R. A., McCabe E. R., Eriksson A. W., Weleber R. G. Negative-configuration electroretinogram in Oregon eye disease. Consistent phenotype in Xp21 deletion syndrome. Arch Ophthalmol. 1993 Nov;111(11):1558–1563. doi: 10.1001/archopht.1993.01090110124037. [DOI] [PubMed] [Google Scholar]
  22. Pillers D. A., Weleber R. G., Woodward W. R., Green D. G., Chapman V. M., Ray P. N. mdxCv3 mouse is a model for electroretinography of Duchenne/Becker muscular dystrophy. Invest Ophthalmol Vis Sci. 1995 Feb;36(2):462–466. [PubMed] [Google Scholar]
  23. Schmitz F., Drenckhahn D. Dystrophin in the retina. Prog Neurobiol. 1997 Dec;53(5):547–560. doi: 10.1016/s0301-0082(97)00047-6. [DOI] [PubMed] [Google Scholar]
  24. Sieving P. A., Murayama K., Naarendorp F. Push-pull model of the primate photopic electroretinogram: a role for hyperpolarizing neurons in shaping the b-wave. Vis Neurosci. 1994 May-Jun;11(3):519–532. doi: 10.1017/s0952523800002431. [DOI] [PubMed] [Google Scholar]
  25. Sigesmund D. A., Weleber R. G., Pillers D. A., Westall C. A., Panton C. M., Powell B. R., Héon E., Murphey W. H., Musarella M. A., Ray P. N. Characterization of the ocular phenotype of Duchenne and Becker muscular dystrophy. Ophthalmology. 1994 May;101(5):856–865. doi: 10.1016/s0161-6420(13)31249-4. [DOI] [PubMed] [Google Scholar]
  26. Walker A. P., Laing N. G., Yamada T., Chandler D. C., Kakulas B. A., Bartlett R. J. A TaqI map of the dystrophin gene useful for deletion and carrier status analysis. J Med Genet. 1992 Jan;29(1):14–19. doi: 10.1136/jmg.29.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. White R. A., Peters L. L., Adkison L. R., Korsgren C., Cohen C. M., Lux S. E. The murine pallid mutation is a platelet storage pool disease associated with the protein 4.2 (pallidin) gene. Nat Genet. 1992 Sep;2(1):80–83. doi: 10.1038/ng0992-80. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES